An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor

Molecular Pharmacology

Volumn 53, Issue 5, 1998, Pages 894-901

  Kosugi, Shinji ^a,c   Mori, Toru ^a   Shenker, Andrew ^b,d  

^a KYOTO UNIVERSITY   (Japan)

^b NORTHWESTERN UNIVERSITY   (United States)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; GENE MUTATION; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; NONHUMAN; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PROTEIN CONFORMATION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; ASPARTIC ACID; CHORIONIC GONADOTROPIN; COS CELLS; CYCLIC AMP; HUMANS; INOSITOL PHOSPHATES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; RECEPTORS, LH; RECOMBINANT PROTEINS;

EID: 0031780235     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Altenbach C, Yang K, Farrens DL, Khorana HG, and Hubbell WL (1996) Structural feature and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: A site-directed spin-labeling study. Biochemistry 35:12470-12478.
2. Arnis S, Fahmy K, Hofmann KP, and Sakmar TP (1994) A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J Biol Chem 269:23879-23881.
3. Baldwin JM, Schertler GFX, and Unger VM (1997) An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol 272:144-164.
4. Cohen GB, Yang T, Robinson PR, and Oprian DD (1993) Constitutive activation of opsin: Influence of charge at position 134 and size at position 296. Biochemistry 32:6111-6115.
5. Farrens DL, Altenbach C, Yang K, Hubbell WL, and Khorana HG (1996) Light activation of rhodopsin requires rigid body motion of transmembrane helices. Science (Washington DC) 274:768-770.
6. Gilchrist RL, Ryu K-S, Ji I, and Ji TH (1996) The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J Biol Chem 271:19283-19287.
7. Gromoll J, Simoni M, and Nieschlag E (1996) An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 81:1367-1370.
8. 2+ mobilization: Studies with the cloned murine luteinizing hormone receptor expressed in L cells. J Biol Chem 267:4479-4488.
9. Han M, Lin SW, Minkova M, Smith SO, and Sakmar TP (1996) Functional helix-helix interactions in rhodopsin: replacement of phenylalanine 261 by alanine causes reversion of phenotype of a glycine 121 replacement mutant. J Biol Chem 271:32337-32342.
10. Högger P, Shockley MS, Lameh J, and Sadée W (1995) Activating and inactivating mutations in N-and C-terminal i3 loop junctions of muscarinic acetylcholine Hm 1 receptors. J Biol Chem 270:7405-7410.
11. 1-adrenergic receptor activation. Biochemistry 36:633-639.
12. Konopka JB, Margarit SM, and Dube P (1996) Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled α-factor receptor. Proc Natl Acad Sci USA 93:6764-6769.
13. Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, and Kohn LD (1993) Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoanti-body-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation. Mol Endocrinol 7:1009-1020.
14. 578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J Biol Chem 271:31813-31817.
15. Kosugi S, Lin Z, Pearlstein R, Mori T, and Shenker A (1997) Evidence that interhelical hydrogen bonding between Asp 578 and Asn 619 helps maintain the inactive conformation of the human lutropin receptor (LHR). Program and Abstracts, The Endocrine Society 79th Annual Meeting, p. 171.
16. Kraaij R, Post M, Kremer H, Milgrom E, Epping W, Brunner HG, Grootegoed JA, and Themmen APN (1995) A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 80:3168-3172.
17. Kraaij R (1996) Expression and activation of gonadotropin receptors. Ph.D. Thesis, Erasmus University, Rotterdam.
18. Kudo M, Osuga Y, Kobilka BK, and Hsueh AJW (1996) Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J Biol Chem 271:22470-22478.
19. Laue L, Chan W-Y, Hsueh AJW, Kudo M, Hsu SY, Wu S-M, Blomberg L, and Cutler GB Jr (1995) Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA 92:1906-1910.
20. Lefkowitz RJ, Cotecchia S, Samama P, and Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
21. LiCata VJ and Ackers GK (1995) Long-range, small magnitude nonadditivity of mutational effects in proteins. Biochemistry 34:3133-3139.
22. Lin Z, Shenker A, and Pearlstein R (1997) A model of the lutropin/choriogonadotropin receptor: Insights into the structural and functional effects of constitutively activating mutations. Protein Eng 10:501-510.
23. Liu J, Blin N, Conklin BR, and Wess J (1996) Molecular mechanisms involved in muscarinic acetylcholine receptor-mediated G protein activation studied by insertion mutagenesis. J Biol Chem 271:6172-6178.
24. Mildvan AS, Weber DJ, and Kuliopulos A (1992) Quantitative interpretations of double mutations of enzymes. Arch Biochem Biophys 294:327-340.
25. Munson PJ and Rodbard D (1980) LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
26. 2-adrenergic receptor: Localization of regions involved in G protein-receptor coupling. J Biol Chem 263:15985-15992.
27. Parent J-L, Le Gouill C, de Brum-Fernandes AJ, Rola-Pleszczynski M, and Stanková J (1996) Mutations of two adjacent amino acids generate inactive and constitutively active forms of the human platelet-activating factor receptor. J Biol Chem 271:7949-7955.
28. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, and Vassart G (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (Lond.) 365:649-651.
29. Probst WC, Snyder LA, Schuster DI, Brosius J, and Sealfon SC (1992) Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 11:1-20.
30. 1B-adrenergic receptor: Potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 94:808-813.
31. Schipani E, Langman CB, Parfitt AM, Jensen S, Kikuchi S, Kooh SW, Cole WG, and Jüppner H (1996) Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med 335:736-738.
32. Sealfon SC, Chi L, Ebersole BJ, Rodic V, Zhang D, Ballesteros JA, and Weinstein H (1995) Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor. J Biol Chem 270:16683-16688.
33. Segaloff DL and Ascoli M (1993) The lutropin/choriogonadotropin receptor ... 4 years later. Endocr Rev 14:324-347.
34. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, and Cutler GB Jr (1993) A Constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature (Lond.) 365:652-654.
35. Smith SO, Smith CS, and Bormann BJ (1996) Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erb-2 receptor. Nat Struct Biol 3:252-258.
36. Spalding T A, Burstein ES, Brauner-Osborne H, Hill-Eubanks D, and Brann MR (1995) Pharmacology of a Constitutively active muscarinic receptor generated by random mutagenesis. J Pharmacol Exp Ther 275:1274-1279.
37. Spudich JL and Lanyi JK (1996) Shuttling between two protein conformations: The common mechanism for sensory transduction and ion transport. Curr Opin Cell Biol 8:452-457.
38. Themmen APN and Brunner HG (1996) Luteinizing hormone receptor mutations and sex differentiation. Eur J Endocrinol 134:533-540.
39. Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, and Parma J (1996) Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554.
40. Wang Z, Wang H, and Ascoli M (1993) Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/ chorionic gonadotropin receptor. Mol Endocrinol 7:85-93.